Ipratropium: Difference between revisions
Ajgausepohl (talk | contribs) (edits) |
Ajgausepohl (talk | contribs) (edits) |
||
| Line 9: | Line 9: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
[[Asthma]] | |||
*Children ≤5 years: 0.25 mg Neb q20mins, up to 3 doses | |||
*Children ≤12 years: 0.25-0.5 mg Neb q20mins, up to 3 doses | |||
*Children >12 years: Refer to adult dosing | |||
==Special Populations== | ==Special Populations== | ||
Revision as of 00:58, 2 June 2015
General
- Type: Anticholinergic Agent
- Dosage Forms: Oral inhalation
- Common Trade Names: Atrovent
Adult Dosing
Asthma - 0.5mg Nebulized q20min, up to 3 doses
COPD - 0.5mg Nebulized q20mins, up to 3 doses
Pediatric Dosing
- Children ≤5 years: 0.25 mg Neb q20mins, up to 3 doses
- Children ≤12 years: 0.25-0.5 mg Neb q20mins, up to 3 doses
- Children >12 years: Refer to adult dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: